Open AccessRituximab: A Magic Bullet for Pemphigus
Author(s) -
V. Anandan,
W. Afthab Jameela,
R Sowmiya,
M Mani Surya Kumar,
P Lavanya
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/21868.9717
Subject(s) - rituximab , medicine , pemphigus , adverse effect , pemphigus vulgaris , cyclophosphamide , rheumatoid arthritis , refractory (planetary science) , surgery , dermatology , chemotherapy , lymphoma , physics , astrobiology
Pemphigus, an autoimmune disease, was fatal before the era of corticosteroids. With the advent of steroids, mortality decreased but morbidity was present due to the side effects of high dose steroids. Newer drugs targeted at the molecular level are said to have fewer side effects and improved effectiveness.